These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1604678)

  • 21. Sensor Augmented Pump Therapy Use in Type 1 Diabetes Mellitus.
    Carolan E; Murphy NP
    Ir Med J; 2016 Dec; 109(10):477. PubMed ID: 28644582
    [No Abstract]   [Full Text] [Related]  

  • 22. New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
    Rieger C; Kurz K; Mueller-Hoffmann W; Gehr B; Liebl A
    J Diabetes Sci Technol; 2019 Nov; 13(6):1158-1160. PubMed ID: 31195815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost benefits of intensive insulin therapy using injections, external pumps and implantable pumps].
    Selam JL; Haardt MJ; Berne C; Dorange C; Lanoe JL; Bethoux JP; Slama G
    Diabete Metab; 1993 Dec; 19(5 Suppl):506-9. PubMed ID: 8206188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.
    Bragd J; von Döbeln A; Lins PE; Adamson U; Bergström J; Oskarsson P
    Diabetes Technol Ther; 2010 Sep; 12(9):689-93. PubMed ID: 20687863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].
    Guerci B; Jeandidier N; Lassmann-Vague V; Renard E; Hanaire-Broutin H
    Diabetes Metab; 2000 Dec; 26(6):513-9. PubMed ID: 11173725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and perinatal outcomes in pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion and real time continuous glucose monitoring in two specialized centers in Medellin, Colombia.
    Restrepo-Moreno M; Ramírez-Rincón A; Hincapié-García J; Palacio A; Monsalve-Arango C; Aristizabal-Henao N; Restrepo-Zapata C; Botero-Arango JF
    J Matern Fetal Neonatal Med; 2018 Mar; 31(6):696-700. PubMed ID: 28264604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients.
    Yardley JE; Iscoe KE; Sigal RJ; Kenny GP; Perkins BA; Riddell MC
    Diabetes Technol Ther; 2013 Jan; 15(1):84-8. PubMed ID: 23216304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes.
    Chimenti EM; de la Morena LH; Vaquero PM; Sáez-de-Ibarra L; Domínguez MG; Sánchez LF
    Diabetes Res Clin Pract; 2010 Dec; 90(3):e57-9. PubMed ID: 20855123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 1 diabetes: treatment and prevention.
    Hitman GA
    Diabet Med; 2011 Oct; 28(10):1139. PubMed ID: 21923695
    [No Abstract]   [Full Text] [Related]  

  • 34. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Usage of Insulin Pump Functions Not Associated With Improved HbA1c in Children and Adolescents With Type 1 Diabetes Mellitus.
    Sandberg H; Anderberg P; Forssell H; Ovhed I; Berglund J
    J Diabetes Sci Technol; 2016 Jul; 10(4):997-8. PubMed ID: 26721525
    [No Abstract]   [Full Text] [Related]  

  • 36. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
    Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C
    Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The diabetic child and the specifics of insulin therapy].
    Dirlewanger M; Perrenoud L; Castellsague-Perolini M; Schwitzgebel VM
    Rev Med Suisse; 2007 Apr; 3(107):994-1000. PubMed ID: 17526373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.
    Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K
    Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive management of type 1 diabetes in young children.
    Kaufman FR
    Lancet; 2005 Feb 26-Mar 4; 365(9461):737-8. PubMed ID: 15733703
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII.
    Anderson DG
    Pediatr Diabetes; 2009 Aug; 10(5):304-9. PubMed ID: 19076301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.